146 related articles for article (PubMed ID: 16107759)
41. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
Shaw PH; Olszewski M; Kletzel M
J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
[TBL] [Abstract][Full Text] [Related]
42. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro.
Dvorak AM; Seder RA; Paul WE; Morgan ES; Galli SJ
Am J Pathol; 1994 Jan; 144(1):160-70. PubMed ID: 7507298
[TBL] [Abstract][Full Text] [Related]
43. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis.
Castells MC; Friend DS; Bunnell CA; Hu X; Kraus M; Osteen RT; Austen KF
J Allergy Clin Immunol; 1996 Oct; 98(4):831-40. PubMed ID: 8876560
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-3 does not affect the differentiation of mast cells derived from human bone marrow progenitors.
Shimizu Y; Matsumoto K; Okayama Y; Sakai K; Maeno T; Suga T; Miura T; Takai S; Kurabayashi M; Saito H
Immunol Invest; 2008; 37(1):1-17. PubMed ID: 18214796
[TBL] [Abstract][Full Text] [Related]
45. Induction of human leukaemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor.
Grabbe J; Welker P; Grützkau A; Dippel E; Nürnberg W; Zuberbier T; Henz BM
Scand J Immunol; 1998 Apr; 47(4):324-31. PubMed ID: 9600313
[TBL] [Abstract][Full Text] [Related]
46. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
Lantz CS; Huff TF
J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
[TBL] [Abstract][Full Text] [Related]
47. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
48. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
[TBL] [Abstract][Full Text] [Related]
49. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
50. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
51. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells.
Welker P; Grabbe J; Zuberbier T; Guhl S; Henz BM
J Invest Dermatol; 2000 Jan; 114(1):44-50. PubMed ID: 10620114
[TBL] [Abstract][Full Text] [Related]
52. Quantitative assessment of the stem cell self-renewal capacity.
Nakauchi H; Sudo K; Ema H
Ann N Y Acad Sci; 2001 Jun; 938():18-24; discussion 24-5. PubMed ID: 11458506
[TBL] [Abstract][Full Text] [Related]
53. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand.
Mitsui H; Furitsu T; Dvorak AM; Irani AM; Schwartz LB; Inagaki N; Takei M; Ishizaka K; Zsebo KM; Gillis S
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):735-9. PubMed ID: 7678463
[TBL] [Abstract][Full Text] [Related]
54. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
[TBL] [Abstract][Full Text] [Related]
55. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors.
Price MM; Kapitonov D; Allegood J; Milstien S; Oskeritzian CA; Spiegel S
FASEB J; 2009 Oct; 23(10):3506-15. PubMed ID: 19535686
[TBL] [Abstract][Full Text] [Related]
56. Stem cell factor and IL-6 do not promote complete maturation of human cultured mast cells from umbilical cord blood cells: an ultrastructural study.
Matsushima Y; Ishikawa O; Kurosawa M; Miyachi Y
J Dermatol Sci; 2000 Sep; 24(1):4-13. PubMed ID: 10960774
[TBL] [Abstract][Full Text] [Related]
57. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
58. Regulation of human intestinal mast cells by stem cell factor and IL-4.
Lorentz A; Bischoff SC
Immunol Rev; 2001 Feb; 179():57-60. PubMed ID: 11292028
[TBL] [Abstract][Full Text] [Related]
59. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture.
Ariyama Y; Misawa S; Sonoda Y
Stem Cells; 1995 Jul; 13(4):404-13. PubMed ID: 7549899
[TBL] [Abstract][Full Text] [Related]
60. The potential of human mast cell progenitors to differentiate into mature mast cells remains after prolonged culture with flt3 ligand, interleukin-3 or granulocyte-macrophage colony stimulating factor.
Hjertson M; Sundström C; Nilsson K; Nilsson G
Br J Haematol; 1999 Mar; 104(3):516-22. PubMed ID: 10086789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
